Año: 2011
Journal Impact Factor (JIF): 11,675
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| GASTROENTEROLOGY & HEPATOLOGY | SCIE | 1/74 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 4,690
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| GASTROENTEROLOGY & HEPATOLOGY | 1/124 | Q1 | T1 | D1 | 99,60 |
Año:
2011
CiteScore:
16,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Gastroenterology | 1/118 | Q1 | T1 | D1 |
| General Medicine | 82/3161 | Q1 | T1 | D1 |
SJR año:
2011
Factor de Impacto:
4,018
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Gastroenterology | 1/132 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Abbott | - |
| CTSA (Indiana) | UL1 RR025761; UL1 RR025747; UL1 UL1 RR024986 |
| Daiichi-Sankyo | - |
| EC | QLRI-CT-2002-02757 |
| GlaxoSmithKline | - |
| Instituto de Salud Carlos III | - |
| International Serious Adverse Events Consortium | - |
| Johnson Johnson | - |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2U01-DK065211-06; 5U01DK065193-04; 5U01-DK065238-08; 2U01-DK065176-06; 2U01-DK065201-06; 2U01-DK065184-06 |
| Novartis | - |
| Pfizer | - |
| Roche | - |
| SAEC and Boehringer-Ingelheim, Barcelona, Spain | - |
| Sanofi-Aventis | - |
| Spanish Medicine Agency | - |
| Takeda | - |
| UK Department of Health | PHGX10A |
| UK NIHR | - |
| Wellcome Trust | - |
| Wyeth | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Lucena, María Isabel | Hospital Universitari Virgen de la Victoria (Spain) |
| 2 | Molokhia, Mariam | King's College London (United Kingdom) |
| 3 | Shen, Yufeng | Columbia University in the City of New York (United States) |
| 4 | Urban, Thomas J. | Duke University (United States) |
| 5 | Aithal, Guruprasad P. | University of Nottingham Medical School (United Kingdom) |
| 6 | Andrade, Raúl J. | Hospital Universitari Virgen de la Victoria (Spain) |
| 7 | Day, Christopher P. | School of Medical Education (United Kingdom) |
| 8 | Ruiz-Cabello, Francisco | Complejo Hospitalario Universitario de Granada; Red Genómica del Cáncer (Spain) |
| 9 | Donaldson, Peter T. | School of Medical Education (United Kingdom) |
| 10 | Stephens, Camilla | Hospital Universitari Virgen de la Victoria (Spain) |
| 11 | Pirmohamed, Munir | University of Liverpool (United Kingdom) |
| 12 | Romero-Gómez, Manuel | Hospital Universitario de Valme (Spain) |
| 13 | Navarro, José María | Hospital Costa Del Sol (Spain) |
| 14 | Fontana, Robert J. | University of Michigan Medical School (United States) |
| 15 | Miller, Michael | University of Dundee School of Medicine (United Kingdom) |
| 16 | Groome, Max | University of Dundee School of Medicine (United Kingdom) |
| 17 | Bondon-Guitton, Emmanuelle | Université Fédérale Toulouse Midi-Pyrénées (France) |
| 18 | Conforti, Anita | Ospedale Policlinico (Italy) |
| 19 | Stricker, Bruno H.C. | Erasmus MC (Netherlands) |
| 20 | Carvajal, Alfonso | Universidad de Valladolid (Spain) |
| 21 | Ibáñez, Luisa | Foundation Catalan Institute of Pharmacology (Spain) |
| 22 | Yue, Qun-Ying | Medical Products Agency (Sweden) |
| 23 | Eichelbaum, Michel | Universität Tübingen (Germany) |
| 24 | Floratos, Aris | Columbia University in the City of New York (United States) |
| 25 | Pe'Er, Itsik | Columbia University in the City of New York (United States) |
| 26 | Daly, Mark J. | Harvard Medical School (United States) |
| 27 | Goldstein, David B. | Duke University (United States) |
| 28 | Dillon, John F. | University of Dundee School of Medicine (United Kingdom) |
| 29 | Nelson, Matthew R. | GlaxoSmithKline, USA (United States) |
| 30 | Watkins, Paul B. | Hamner-UNC (United States) |
| 31 | School of Medical Education (United Kingdom) |
